
Tokens or Royalties: Boltz, Isomorphic and Who Captures Value When Drug Design Moves to Compute
Dr. Dereck Mush, MD, MBABessemer Venture Partners is a venture capital firm. On November 18, 2026, it led the $110 million Series A of Boltz. Partners Andrew Hedin and Byron Deeter joined Boltz's journey, according to the Boltz announcement.
How Bessemer Venture Partners got here, step by step.
18 November 2026
Led the $110 million Series A of Boltz. Partners Andrew Hedin and Byron Deeter joined Boltz's journey, according to the Boltz announcement.
18 November 2026
Bessemer on Boltz molecular design18 November 2026
Boltz Series A announcement
Dr. Dereck Mush, MD, MBAMentions Bessemer Venture Partners
Related companies
Your daily HealthTech Signal
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: